毛利率约50%！妈咪爱、易坦静的中国分销商冲击IPO，年入近20亿，总部位于香港

Core Viewpoint - The article discusses the upcoming IPO of the Chinese distributors of MammyCare and Yitanjing, highlighting their significant revenue and profitability metrics, including a gross margin of approximately 50% and annual revenue nearing 2 billion yuan [1]. Group 1 - The companies are based in Hong Kong and are preparing to launch their IPO, indicating a strategic move to raise capital for further growth [1]. - The annual revenue of nearly 2 billion yuan reflects strong market demand and effective distribution strategies within the Chinese healthcare sector [1]. - The gross margin of around 50% suggests a healthy profitability level, which is attractive for potential investors [1].